$4.300
-0.391 (-9.09%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
DERM-Prognose durch Analyse ähnlicher Charts
Alphio's DERM stock price prediction model matches the current Journey Medical Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.26 (-0.83%). The 1-week path is $4.32 (+0.41%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Journey Medical Corp-Aktien kaufen?
Journey Medical Corp (DERM) is a good buy right now due to its recent strong earnings growth, with a reported revenue of $18.5 million in Q2 2026, a 23% increase year-over-year, and a significant reduction in net loss to $300,000, or $0.01 per share. The current price of $4.79 is well below the analyst price target of $15, indicating substantial upside potential. However, the RSI is at 33.735, suggesting that the stock is currently oversold, which could present a buying opportunity. The main risk is the forward P/E ratio of 20.70, indicating that the stock may be overvalued if earnings do not improve as expected.
DERM schloss am Thursday bei $4.30, nachdem der Kurs -9.09% fallen
Journey Medical Corp (DERM) last closed at $4.3000002, losing -9.09%. These facts feed the 1-day and 1-week DERM price prediction above.
Analystenkonsens
Journey Medical Corp (DERM): 7 Kaufen, 0 Halten, 1 Verkaufen. Ausblick: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Prognose-Treiber
Die Prognose-Treiber von Journey Medical Corp (DERM) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf DERM am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für DERM
Historically the probability of a positive November return for DERM is 67.44%. November offers the highest probability of a positive month at 67.44%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-Jahres-Kursprojektionen für DERM
| Monat | Tiefstkurs | Ø-Kurs | Höchstkurs | Potenzieller ROI |
|---|---|---|---|---|
| Nov 2026 | $6.28 | $7.19 | $10.26 | +67.11% |
| Dec 2026 | $6.37 | $8.61 | $10.87 | +100.30% |
Für 2026 wird für Journey Medical Corp (DERM) eine Spanne von $6.28 bis $10.87 projiziert.
Monatsprognose 2026 für Journey Medical Corp
Im Nov 2026 wird für Journey Medical Corp ein Durchschnitt von $7.19 erwartet, mit einem Tief von $6.28 und einem Hoch von $10.26.
Im Dec 2026 wird für Journey Medical Corp ein Durchschnitt von $8.61 erwartet, mit einem Tief von $6.37 und einem Hoch von $10.87.
Ähnliche Artikel
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.